Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Róbert Kiss

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Orvosi Hetilap|May 19, 2010
[Interview with Dr. Róbert Kiss by Györgyi B. Király]Róbert Kiss
Orvosi Hetilap|November 29, 2016
[Prof. Edit Gláz has turned 90]Róbert Kiss
Expert Opinion on Therapeutic Patents|September 16, 2014
Novel histamine H4 receptor ligands and their potential therapeutic applications: an updateRóbert Kiss, György M Keseru
Expert Opinion on Therapeutic Patents|May 16, 2009
Histamine H4 receptor ligands and their potential therapeutic applicationsRóbert Kiss, György M Keseru
Expert Opinion on Drug Discovery|October 6, 2016
Structure-based discovery and binding site analysis of histamine receptor ligandsRóbert Kiss, György M Keserű
Expert Opinion on Therapeutic Patents|March 6, 2012
Histamine H4 receptor ligands and their potential therapeutic applications: an updateRóbert Kiss, György M Keserű
Journal of Pharmaceutical and Biomedical Analysis|August 2, 2017
What NMR can do in the biopharmaceutical industryRóbert Kiss, Ádám Fizil, Csaba Szántay
Journal of Chemical Information and Modeling|May 13, 2010
Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexesMárk Sándor, Róbert Kiss, György M Keseru
European Journal of Medicinal Chemistry|October 27, 2004
Homology modelling and binding site mapping of the human histamine H1 receptorRóbert Kiss, Zoltán Kovári, György M Keseru
RSC Medicinal Chemistry|May 12, 2025
A data-driven journey using results from target-based drug discovery for target deconvolution in phenotypic screeningGergely Takács, György T Balogh, Róbert Kiss
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Orvosi Hetilap|May 19, 2010
[Interview with Dr. Róbert Kiss by Györgyi B. Király]Róbert Kiss
Orvosi Hetilap|November 29, 2016
[Prof. Edit Gláz has turned 90]Róbert Kiss
Expert Opinion on Therapeutic Patents|September 16, 2014
Novel histamine H4 receptor ligands and their potential therapeutic applications: an updateRóbert Kiss, György M Keseru
Expert Opinion on Therapeutic Patents|May 16, 2009
Histamine H4 receptor ligands and their potential therapeutic applicationsRóbert Kiss, György M Keseru
Expert Opinion on Drug Discovery|October 6, 2016
Structure-based discovery and binding site analysis of histamine receptor ligandsRóbert Kiss, György M Keserű
Expert Opinion on Therapeutic Patents|March 6, 2012
Histamine H4 receptor ligands and their potential therapeutic applications: an updateRóbert Kiss, György M Keserű
Journal of Pharmaceutical and Biomedical Analysis|August 2, 2017
What NMR can do in the biopharmaceutical industryRóbert Kiss, Ádám Fizil, Csaba Szántay
Journal of Chemical Information and Modeling|May 13, 2010
Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexesMárk Sándor, Róbert Kiss, György M Keseru
European Journal of Medicinal Chemistry|October 27, 2004
Homology modelling and binding site mapping of the human histamine H1 receptorRóbert Kiss, Zoltán Kovári, György M Keseru
RSC Medicinal Chemistry|May 12, 2025
A data-driven journey using results from target-based drug discovery for target deconvolution in phenotypic screeningGergely Takács, György T Balogh, Róbert Kiss
Pageof 5